Systemic pregabalin attenuates sensorimotor responses and medullary glutamate release in inflammatory tooth pain model

Neuroscience

Volumn 218, Issue , 2012, Pages 359-366

  Narita, N ^a   Kumar, N ^b,c   Cherkas, P S ^c   Chiang, C Y ^c   Dostrovsky, J O ^c,d   Coderre, T J ^b   Sessle, B J ^c,d  

^a NIHON UNIVERSITY   (Japan)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Glutamate release; Mustard oil; Pregabalin; Sensorimotor behavior; Tooth pulp inflammation

Indexed keywords

GLUTAMIC ACID; MINERAL OIL; PREGABALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; DRUG RESPONSE; ELECTROMYOGRAM; IN VIVO STUDY; JAW; MALE; MASSETER MUSCLE; MEDULLA OBLONGATA; MICRODIALYSIS; MOLAR TOOTH; NOCICEPTION; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SPINAL CORD DORSAL HORN; TONGUE; TOOTH PAIN; TOOTH PULP;

ANALGESICS; ANIMALS; DENTAL PULP; DISEASE MODELS, ANIMAL; ELECTROMYOGRAPHY; FACIAL MUSCLES; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; INFLAMMATION; IRRITANTS; MALE; MEDULLA OBLONGATA; MICRODIALYSIS; MUSTARD PLANT; PLANT OILS; RATS; RATS, SPRAGUE-DAWLEY; TOOTHACHE;

EID: 84863779196     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.05.016     Document Type: Article

References (57)

1. Azérad J., Boucher Y., Pollin B. Demonstration of glutamate in primary sensory trigeminal neurons innervating dental pulp in rats. C R Acad Sci III 1992, 314:469-475.
2. Bannister K., Sikandar S., Bauer C.S., Dolphin A.C., Porreca F., Dickenson A.H. Pregabalin suppresses spinal neuronal hyperexcitability and visceral hypersensitivity in the absence of peripheral pathophysiology. Anesthesiol 2011, 115:144-152.
3. Bauer C.S., Nieto-Rostro M., Rahman W., Tran-Van-Minh A., Ferron L., Douglas L., Kadurin I., Sri Ranjan Y., Fernandez-Alacid L., Millar N.S., Dickenson A.H., Lujan R., Dolphin A.C. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J Neurosci 2009, 29:4076-4088.
4. Bauer C.S., Rahman W., Tran-van-Minh A., Lujan R., Dickenson A.H., Dolphin A.C. The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo. Biochem Soc Trans 2010, 38:525-528.
5. Bereiter D.A. Trigeminal brainstem nuclear complex. Immunohistochemistry and neurochemistry. Encyclopedia of pain 2007, 2541-2543. Springer, Heidelberg. R.F. Schmidt, W.D. Willis (Eds.).
6. Bereiter D.A., Benetti A.P. Excitatory amino release within spinal trigeminal nucleus after mustard oil injection into the temporomandibular joint region of the rat. Pain 1996, 67:451-459.
7. Böttcher T., Goiny M., Bering J., Domhof S., Nau R.D., Ungerstedt U. Regional differences in glutamine synthetase inhibition by L-methionine sulfoximine: a microdialysis study in the rabbit brain. Exp Brain Res 2003, 150:194-200.
8. Cairns B.E., Sessle B.J., Hu J.W. Evidence that excitatory amino acid receptors within the temporomandibular joint region are involved in the reflex activation of the jaw muscles. J Neurosci 1998, 18:8056-8064.
9. Cairns B.E., Sessle B.J., Hu J.W. Temporomandibular-evoked jaw muscle reflex: role of brainstem NMDA and non-NMDA receptors. Neuroreport 2001, 12:1875-1878.
10. Cada D.J., Levien T., Baker D.E. Pregabalin. Hosp Pharm 2006, 41:157-172.
11. Cao Y, Wang H, Chiang CY, Dostrovsky JO, Sessle BJ (2011) Effects of pregabalin on nociceptive behavior and central sensitization in a trigeminal neuropathic pain model. Program No. 72.27. Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC.
12. Capra N.F., Ro J.Y. Human and animal experimental models of acute and chronic muscle pain: intramuscular algesic injection. Pain 2004, 110:3-7.
13. Cappuzzo K.A. Treatment of postherapeutic neuralgia: focus on pregabalin. Clin Interv Aging 2009, 4:17-23.
14. Chen S.R., Xu Z., Pan H.L. Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats. Anesthesiol 2001, 95:1473-1479.
15. Cherkas PS, Kumar N, Miyamoto M, Coderre TJ, Dostrovsky JO, Sessle BJ (2010) Pregabalin blocks central sensitization and glutamate release in rodent medullar dorsal horn associated with acute tooth pain. Program No. PW310. Abstract Viewer/Itinerary Planner. International Study for Pain, Montreal.
16. Chiang C.Y., Park S.J., Kwan C.L., Hu J.W., Sessle B.J. NMDA receptor mechanisms contribute to neuroplasticity induced in caudalis nociceptive neurons by tooth pulp stimulation. J Neurophysiol 1998, 80:2621-2631.
17. Chiang C.Y., Li Z., Dostrovsky J.O., Hu J.W., Sessle B.J. Glutamine uptake contributes to central sensitization in the medullary dorsal horn. Neuroreport 2008, 19:1151-1154.
18. Christensen D., Gautron M., Guilbaud G., Kayser V. Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain. Pain 2001, 93:147-153.
19. Coderre T.J., Kumar N., Lefebvre C.D., Yu J.S. A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. J Neurochem 2007, 100:1289-1299.
20. Dubner R., Ren K. Brainstem mechanisms of persistent pain following injury. J Orofac Pain 2004, 18:299-305.
21. 2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 2006, 103:17537-17542.
22. Finnerup N.B., Sindrup S.H., Jensen T.S. The evidence for pharmacological treatment of neuropathic pain. Pain 2010, 150:573-581.
23. Frampton J.E., Foster R.H. Pregabalin in the treatment of postherpetic neuralgia. Drugs 2005, 65:111-118.
24. Freeman R., Durso-Decruz E., Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care 2008, 31:1448-1454.
25. Grabow T.S., Dougherty P.M. Gabapentin produces dose-dependent antinociception in the orofacial formalin test in the rat. Reg Anesth Pain Med 2002, 27:277-283.
26. Henry J.L., Sessle B.J., Lucier G.E., Hu J.W. Effects of substance P on nociceptive and non-nociceptive trigeminal brain stem neurons. Pain 1980, 8:33-45.
27. Hill C.M., Balkenohl M., Thomas D.W., Walker R., Mathé H., Murray G. Pregabalin in patients with postoperative dental pain. Eur J Pain 2001, 5:119-124.
28. Honda K., Kitagawa J., Sessle B.J., Kondo M., Tsuboi Y., Yonehara Y., Iwata K. Mechanisms involved in an increment of multimodal excitability of medullary and upper cervical dorsal horn neurons following cutaneous capsaicin treatment. Mole Pain 2008, 4:59.
29. Hu J.W., Sessle B.J., Raboisson P., Dallel R., Woda A. Stimulation of craniofacial muscle afferents induces prolonged facilitatory effects in trigeminal nociceptive brainstem neurones. Pain 1992, 48:53-60.
30. Kumar N., Laferriere A., Yu J.S., Leavitt A., Coderre T.J. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 2010, 113:552-561.
31. Lam D.K., Sessle B.J., Cairns B.E., Hu J.W. Peripheral NMDA receptor modulation of jaw muscle electromyographic activity induced by capsaicin injection into the temporomandibular joint of rats. Brain Res 2005, 1046:68-76.
32. Lam D.K., Sessle B.J., Hu J.W. Glutamate and capsaicin effects on trigeminal nociception. II: Activation and central sensitization in brainstem neurons with deep craniofacial afferent input. Brain Res 2009, 1253:48-59.
33. Lindsay T.J., Rodgers B.C., Savath V., Hettinger K. Treating diabetic peripheral neuropathic pain. Am Fam Physician 2010, 82:151-158.
34. López-López J., Estrugo-Devesa A., Jané-Salas E., Segura-Egea J.J. Inferior alveolar nerve injury resulting from overextension of an endodontic sealer: non-surgical management using the GABA analogue pregabalin. Int Endod J 2012, 45:98-104.
35. Lotarski S.M., Donevan S., El-Kattan A., Osgood S., Poe J., Taylor C.P., Offord J. Anxiolytic-like activity of pregabalin in the Vogel conflict test in α2δ-1 (R217A) and α2δ-2 (R279A) mouse mutants. J Pharmacol Exp Ther 2011, 338:615-621.
36. Lund J.P., Kolta A., Sessle B.J. Trigeminal motor system. Vol. 9 2009, 1167-1171. Academic Press, Oxford. L. Squire (Ed.).
37. Moulin D.E., Clark A.J., Gilron I., Ware M.A., Watson C.P., Sessle B.J., Coderre T., Morley-Forster P.K., Stinson J., Boulanger A., Peng P., Finley G.A., Taenzer P., Squire P., Dion D., Cholkan A., Gilani A., Gordon A., Henry J., Jovey R., Lynch M., Mailis-Gagnon A., Panju A., Rollman G.B., Velly A. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007, 12:13-21.
38. Narita N, Cherkas PS, Dostrovsky JO, Sessle BJ (2010) Effects of pregabalin on nociceptive sensorimotor behaviour induced by acute tooth pulp inflammation. Program No. 81. 24 Abstract Viewer/Itinerary Planner. Society for Neuroscience, San Diego.
39. Noma N., Tsuboi Y., Kondo M., Matsumoto M., Sessle B.J., Kitagawa J., Kimiko S., Iwata K. Organization of pERK-immunoreactive cells in trigeminal spinal nucleus caudalis and upper cervical cord following capsaicin injection into oral and craniofacial regions in rats. J Comp Neurol 2008, 507:1428-1440.
40. Obermann M., Yoon M.S., Sensen K., Maschke M., Diener H.C., Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 2008, 28:174-181.
41. Offord J, Lotarski S, Peterson J, Galvin S, Strenkowski B, Hain H, Donevan S (2010) Anticonvulsant activity of pregabalin (Lyrica) requires binding to the α2δ1 subunit of voltage sensitive calcium channels, Presented at the American Epilepsy Society - 64th Annual Meeting, San Antonio, TX, December 3-7, 2010.
42. Quintero J.E., Dooley D.J., Pomerleau F., Huettl P., Gerhardt G.A. Amperometric measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical slices: role of voltage-sensitive Ca2+ α2δ-1 subunit. J Pharmacol Exp Ther 2011, 338:240-245.
43. Ro J.Y. Functional role of peripheral glutamate receptors in craniofacial muscle pain and hyperalgesia. Fundamentals of musculoskeletal pain 2008, 33-45. IASP Press, Seattle. T. Graven-Nielsen, L. Arendt-Nielsen, S. Mense (Eds.).
44. Sabatowski R., Gálvez R., Cherry D.A., Jacquot F., Vincent E., Maisonobe P., Versavel M. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004, 109:26-35.
45. Serpell M.G. Neuropathic pain study group. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain 2002, 99:557-566.
46. Sessle B.J. Acute and chronic craniofacial pain: brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit Rev Oral Biol Med 2000, 11:57-91.
47. Sessle B.J. Trigeminal central sensitization. Rev Analg 2005, 8:85-102.
48. Sunakawa M., Chiang C.Y., Sessle B.J., Hu J.W. Jaw electromyographic (EMG) activity induced by application of algesic chemicals to the rat tooth pulp. Pain 1999, 80:493-501.
49. Taylor CP (2003) The biology and pharmacology of calcium channel alpha2-delta proteins. Pfizer Satellite Symposium to the 2003 Society for Neuroscience Meeting. CNS Drug Rev. 10, 183-188. Sheraton New Orleans Hotel, New Orleans, LA November 10, 2003.
50. Teasell R.W., Mehta S., Aubut J.A., Foulon B., Wolfe D.L., Hsieh J.T., Townson A.F. Short C Spinal Cord Injury Rehabilitation Evidence Research Team. A systematic review of pharmacologic treatments of pain after spinal cord injury. Arch Phys Med Rehabil 2010, 91:816-831.
51. Tsai C.M., Chiang C.Y., Yu X.M., Sessle B.J. Involvement of trigeminal subnucleus caudalis (medullary dorsal horn) in craniofacial nociceptive reflex activity. Pain 1999, 81:115-128.
52. Tzellos T.G., Toulis K.A., Goulis D.G., Papazisis G., Zampeli V.A., Vakfari A., Kouvelas D. Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. J Clin Pharm Ther 2010, 35:639-656.
53. Wallin J., Cui J.G., Yakhnitsa V., Schechtmann G., Meyerson B.A., Linderoth B. Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy. Eur J Pain 2002, 6:261-272.
54. Yokoyama T., Maeda Y., Audette K.M., Sluka K.A. Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. J Pain 2007, 8:422-429.
55. Yu X.-M., Sessle B.J., Hu J.W. Differential effects of cutaneous and deep application of inflammatory irritant on mechanoreceptive field properties of trigeminal brain stem nociceptive neurons. J Neurophysiol 1993, 70:1704-1707.
56. Yu X.M., Sessle B.J., Vernon H., Hu J.W. Administration of opiate antagonist naloxone induces recurrence of increased jaw muscle activities related to inflammatory irritant application to rat temporomandibular joint region. J Neurophysiol 1994, 72:1430-1433.
57. Yu X.M., Sessle B.J., Haas D.A., Izzo A., Vernon H., Hu J.W. Involvement of NMDA receptor mechanisms in jaw electromyographic activity and plasma extravasation induced by inflammatory irritant application to temporomandibular joint region of rats. Pain 1996, 68:169-178.